CA2740950A1 — Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity
Assigned to University of British Columbia · Expires 2009-10-15 · 17y expired
What this patent protects
Methods of determining a subj ecf s ototoxicity risk from administration of platmum-coordmatmg compounds having an ototoxicity risk, methods of administering a platmum-coordmatmg compound having an ototoxicity risk and oligonucleotides, peptide nucleic acids, arrays and addressab…
USPTO Abstract
Methods of determining a subj ecf s ototoxicity risk from administration of platmum-coordmatmg compounds having an ototoxicity risk, methods of administering a platmum-coordmatmg compound having an ototoxicity risk and oligonucleotides, peptide nucleic acids, arrays and addressable collections for performing embodiments of the methods are provided herein.
Drugs covered by this patent
- Sodium Thiosulfate (SODIUM THIOSULFATE) · Us Army
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.